Treating breast cancer before surgery
- 30 November 1996
- Vol. 313 (7069) , 1345-1346
- https://doi.org/10.1136/bmj.313.7069.1345
Abstract
Hence the only intervention proved to alter the natural course of breast cancer is effective adjuvant systemic treatment. Despite this, adjuvant prescribing habits have been one of Britain's most volatile therapeutic variables in recent years.5 A new NHS report6 has invoked this variability to help explain startling survival differences (12–23% at five years) reported between specialist and non-specialist breast cancer units.7 The down side of this upbeat view of adjuvant treatment is the …Keywords
This publication has 17 references indexed in Scilit:
- Large differences in survival are not explainedBMJ, 1996
- Specialist surgeons and survival in breast cancerBMJ, 1996
- Survival outcome of care by specialist surgeons in breast cancer: a study of 3786 patients in the west of ScotlandBMJ, 1996
- c-erbB-2 expression and benefit from adjuvant chemotherapy and radiotherapy of breast cancerEuropean Journal Of Cancer, 1995
- Effects of Radiotherapy and Surgery in Early Breast Cancer — An Overview of the Randomized TrialsNew England Journal of Medicine, 1995
- Enhanced Chemoresistance by Elevation of p185neu Levels in HER-2/neu-Transfected Human Lung Cancer CellsJNCI Journal of the National Cancer Institute, 1995
- Management of breast cancer in southeast EnglandBMJ, 1994
- p53-dependent apoptosis modulates the cytotoxicity of anticancer agentsCell, 1993
- Primary Chemotherapy To Avoid Mastectomy in Tumors With Diameters of Three Centimeters or MoreJNCI Journal of the National Cancer Institute, 1990
- THE RESULTS OF OPERATIONS FOR THE CURE OF CANCER OF THE BREAST PERFORMED AT THE JOHNS HOPKINS HOSPITAL FROM JUNE, 1889, TO JANUARY, 1894Annals of Surgery, 1894